Venous Distension in Patients With Aneurysmatic Arterial Disease
NCT ID: NCT02867501
Last Updated: 2017-04-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
98 participants
OBSERVATIONAL
2016-05-31
2017-03-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Abdominal Compartment Syndrome and Ruptured Aortic Aneurysm : Validation of a Predictive Test
NCT02859662
Investigation of the Neurovegetative Pattern in Patients With Thoracic Aortic Aneurysms (TAA)
NCT05703893
Biomechanical and Microstructural Properties of Ascending Aortic Aneurysms
NCT03142074
Development of Ultra-Low Dose CT Based Screening for Aortic Aneurysms
NCT03479164
Follow up of Patients With Aortic Aneurysm by Dosage of Circulant Endothelial Progenitor Cells
NCT02919709
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Aneurysmatic disease
Patients with dilatative arteriopathy (DA) the aortic diameter must be \> 3 cm or the popliteal artery diameter \> 1.5 cm
No interventions assigned to this group
Peripheral arterial occlusive disease
Patients with arterial occlusive disease (PAOD) defined with an Ankle brachial index (ABI) \< 0.9 and positive criteria in the Edinburgh questionnaire.
No interventions assigned to this group
Healthy
Control group of age matched persons without PAOD (ABI \> 0.9) and without DA.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with arterial occlusive disease (PAOD) defined with an Ankle brachial index (ABI) \< 0.9 and positive criteria in the Edinburgh questionnaire
* Patients able to give informed consent
* Control group of age matched persons without PAOD (ABI \> 0.9) and without DA
Exclusion Criteria
* Diabetes
* No given informed consent
* Persons and patients \< 18 years old
* Acute deep venous thrombosis
* History of deep venous thrombosis
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Kantonsspital Baselland Bruderholz
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Janis Christian Bartelt
intern
References
Explore related publications, articles, or registry entries linked to this study.
Jeanneret C, Baldi T, Hailemariam S, Koella C, Gewaltig J, Biedermann BC. Selective loss of extracellular matrix proteins is linked to biophysical properties of varicose veins assessed by ultrasonography. Br J Surg. 2007 Apr;94(4):449-56. doi: 10.1002/bjs.5630.
Jeanneret C, Jager KA, Zaugg CE, Hoffmann U. Venous reflux and venous distensibility in varicose and healthy veins. Eur J Vasc Endovasc Surg. 2007 Aug;34(2):236-42. doi: 10.1016/j.ejvs.2007.03.018. Epub 2007 May 24.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-00375
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.